Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Jager

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Stem Cell Research|February 28, 2024
Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutationsMarta Ribeiro, Joanna Jager, Marta Furtado, et al.
Human Cell|May 18, 2024
Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutationMarta Ribeiro, Joanna Jager, Marta Furtado, et al.
Circulation|April 23, 2019
Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree RelativesGabrielle Norrish, Joanna Jager, Ella Field, et al.
International Journal of Molecular Sciences|February 28, 2020
A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy CohortMaria Bueno Marinas, Rudy Celeghin, Marco Cason, et al.
Stem Cell Research|October 24, 2024
Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic CardiomyopathyJoanna Jager, Marta Ribeiro, Marta Furtado, et al.
The Canadian Journal of Cardiology|December 8, 2020
The Novel Desmin Variant p.Leu115Ile Is Associated With a Unique Form of Biventricular Arrhythmogenic CardiomyopathyAlexandros Protonotarios, Andreas Brodehl, Angeliki Asimaki, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Interleukin-1β Drives Disease Progression in Arrhythmogenic CardiomyopathyVinay R Penna, Junedh M Amrute, Morgan Engel, et al.
JACC. Basic to Translational Science|May 6, 2026
Interleukin-1β Drives Disease Progression in Arrhythmogenic CardiomyopathyVinay R Penna, Junedh M Amrute, Morgan Engel, et al.
European Heart Journal|July 15, 2021
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathyLuis R Lopes, Soledad Garcia-Hernández, Massimiliano Lorenzini, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Stem Cell Research|February 28, 2024
Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutationsMarta Ribeiro, Joanna Jager, Marta Furtado, et al.
Human Cell|May 18, 2024
Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutationMarta Ribeiro, Joanna Jager, Marta Furtado, et al.
Circulation|April 23, 2019
Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree RelativesGabrielle Norrish, Joanna Jager, Ella Field, et al.
International Journal of Molecular Sciences|February 28, 2020
A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy CohortMaria Bueno Marinas, Rudy Celeghin, Marco Cason, et al.
Stem Cell Research|October 24, 2024
Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic CardiomyopathyJoanna Jager, Marta Ribeiro, Marta Furtado, et al.
The Canadian Journal of Cardiology|December 8, 2020
The Novel Desmin Variant p.Leu115Ile Is Associated With a Unique Form of Biventricular Arrhythmogenic CardiomyopathyAlexandros Protonotarios, Andreas Brodehl, Angeliki Asimaki, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Interleukin-1β Drives Disease Progression in Arrhythmogenic CardiomyopathyVinay R Penna, Junedh M Amrute, Morgan Engel, et al.
JACC. Basic to Translational Science|May 6, 2026
Interleukin-1β Drives Disease Progression in Arrhythmogenic CardiomyopathyVinay R Penna, Junedh M Amrute, Morgan Engel, et al.
European Heart Journal|July 15, 2021
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathyLuis R Lopes, Soledad Garcia-Hernández, Massimiliano Lorenzini, et al.
Pageof 1